nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabergoline—Pericarditis constrictive—Mesalazine—Crohn's disease	0.0885	0.209	CcSEcCtD
Cabergoline—HTR7—enteric nervous system—Crohn's disease	0.0427	0.24	CbGeAlD
Cabergoline—HTR7—myenteric nerve plexus—Crohn's disease	0.0324	0.182	CbGeAlD
Cabergoline—HTR2A—enteric nervous system—Crohn's disease	0.0267	0.15	CbGeAlD
Cabergoline—HTR2A—myenteric nerve plexus—Crohn's disease	0.0202	0.114	CbGeAlD
Cabergoline—Pleurisy—Mesalazine—Crohn's disease	0.0173	0.0409	CcSEcCtD
Cabergoline—Pericardial effusion—Mesalazine—Crohn's disease	0.0103	0.0244	CcSEcCtD
Cabergoline—Prostatic disorder—Mesalazine—Crohn's disease	0.00996	0.0235	CcSEcCtD
Cabergoline—Pericarditis—Mesalazine—Crohn's disease	0.00979	0.0231	CcSEcCtD
Cabergoline—Duodenal ulcer—Mesalazine—Crohn's disease	0.00876	0.0207	CcSEcCtD
Cabergoline—Upset stomach—Mesalazine—Crohn's disease	0.00646	0.0153	CcSEcCtD
Cabergoline—HTR7—mouth—Crohn's disease	0.00554	0.0311	CbGeAlD
Cabergoline—Pleural effusion—Mesalazine—Crohn's disease	0.00553	0.013	CcSEcCtD
Cabergoline—Neoplasm malignant—Azathioprine—Crohn's disease	0.00545	0.0128	CcSEcCtD
Cabergoline—ADRA1D—epithelium—Crohn's disease	0.00541	0.0304	CbGeAlD
Cabergoline—DRD5—lymphoid tissue—Crohn's disease	0.0052	0.0292	CbGeAlD
Cabergoline—Acne—Mesalazine—Crohn's disease	0.00503	0.0119	CcSEcCtD
Cabergoline—Breast pain—Mesalazine—Crohn's disease	0.00485	0.0115	CcSEcCtD
Cabergoline—Dysmenorrhoea—Mesalazine—Crohn's disease	0.00466	0.011	CcSEcCtD
Cabergoline—Arthropathy—Mesalazine—Crohn's disease	0.00466	0.011	CcSEcCtD
Cabergoline—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00429	0.0101	CcSEcCtD
Cabergoline—Influenza like illness—Mesalazine—Crohn's disease	0.00411	0.0097	CcSEcCtD
Cabergoline—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00389	0.00918	CcSEcCtD
Cabergoline—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00386	0.00911	CcSEcCtD
Cabergoline—HTR2B—smooth muscle tissue—Crohn's disease	0.00363	0.0204	CbGeAlD
Cabergoline—HTR2B—skin of body—Crohn's disease	0.00358	0.0201	CbGeAlD
Cabergoline—Alopecia—Mercaptopurine—Crohn's disease	0.00346	0.00817	CcSEcCtD
Cabergoline—HTR7—epithelium—Crohn's disease	0.00322	0.0181	CbGeAlD
Cabergoline—Delusion—Prednisone—Crohn's disease	0.00317	0.00747	CcSEcCtD
Cabergoline—ADRA1A—epithelium—Crohn's disease	0.00311	0.0175	CbGeAlD
Cabergoline—HTR7—smooth muscle tissue—Crohn's disease	0.00311	0.0175	CbGeAlD
Cabergoline—Osteoarthritis—Mesalazine—Crohn's disease	0.00307	0.00725	CcSEcCtD
Cabergoline—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00305	0.0072	CcSEcCtD
Cabergoline—Face oedema—Mesalazine—Crohn's disease	0.00297	0.007	CcSEcCtD
Cabergoline—Arthralgia—Mercaptopurine—Crohn's disease	0.0029	0.00685	CcSEcCtD
Cabergoline—Blood creatinine increased—Mesalazine—Crohn's disease	0.00288	0.0068	CcSEcCtD
Cabergoline—HTR2B—digestive system—Crohn's disease	0.00286	0.0161	CbGeAlD
Cabergoline—Liver function test abnormal—Mesalazine—Crohn's disease	0.00284	0.0067	CcSEcCtD
Cabergoline—Orthostatic hypotension—Mesalazine—Crohn's disease	0.00281	0.00663	CcSEcCtD
Cabergoline—Abdominal pain upper—Mesalazine—Crohn's disease	0.00281	0.00663	CcSEcCtD
Cabergoline—Abdominal discomfort—Azathioprine—Crohn's disease	0.0028	0.0066	CcSEcCtD
Cabergoline—Oedema—Mercaptopurine—Crohn's disease	0.00278	0.00657	CcSEcCtD
Cabergoline—Gastritis—Mesalazine—Crohn's disease	0.00272	0.00642	CcSEcCtD
Cabergoline—Acne—Prednisone—Crohn's disease	0.00266	0.00628	CcSEcCtD
Cabergoline—Influenza—Mesalazine—Crohn's disease	0.00266	0.00627	CcSEcCtD
Cabergoline—Anorexia—Mercaptopurine—Crohn's disease	0.00265	0.00626	CcSEcCtD
Cabergoline—Pneumonia—Azathioprine—Crohn's disease	0.00262	0.00617	CcSEcCtD
Cabergoline—ADRA2C—mammalian vulva—Crohn's disease	0.00257	0.0144	CbGeAlD
Cabergoline—Bronchitis—Mesalazine—Crohn's disease	0.00256	0.00603	CcSEcCtD
Cabergoline—Abdominal discomfort—Mesalazine—Crohn's disease	0.00255	0.00601	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00254	0.00598	CcSEcCtD
Cabergoline—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00247	0.00583	CcSEcCtD
Cabergoline—Arthropathy—Prednisone—Crohn's disease	0.00246	0.00581	CcSEcCtD
Cabergoline—HTR7—digestive system—Crohn's disease	0.00245	0.0138	CbGeAlD
Cabergoline—Decreased appetite—Mercaptopurine—Crohn's disease	0.00242	0.00571	CcSEcCtD
Cabergoline—Weight increased—Mesalazine—Crohn's disease	0.00242	0.00571	CcSEcCtD
Cabergoline—Weight decreased—Mesalazine—Crohn's disease	0.0024	0.00567	CcSEcCtD
Cabergoline—ADRA1A—lymphoid tissue—Crohn's disease	0.0024	0.0135	CbGeAlD
Cabergoline—Pneumonia—Mesalazine—Crohn's disease	0.00238	0.00562	CcSEcCtD
Cabergoline—Depression—Mesalazine—Crohn's disease	0.00236	0.00557	CcSEcCtD
Cabergoline—Urinary tract infection—Mesalazine—Crohn's disease	0.0023	0.00543	CcSEcCtD
Cabergoline—Epistaxis—Mesalazine—Crohn's disease	0.00223	0.00527	CcSEcCtD
Cabergoline—Rhinitis—Mesalazine—Crohn's disease	0.00213	0.00503	CcSEcCtD
Cabergoline—Oedema peripheral—Mesalazine—Crohn's disease	0.0021	0.00494	CcSEcCtD
Cabergoline—Arrhythmia—Azathioprine—Crohn's disease	0.00209	0.00492	CcSEcCtD
Cabergoline—Alopecia—Azathioprine—Crohn's disease	0.00206	0.00487	CcSEcCtD
Cabergoline—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00205	0.00484	CcSEcCtD
Cabergoline—ADRA2A—mammalian vulva—Crohn's disease	0.00205	0.0115	CbGeAlD
Cabergoline—HTR2A—epithelium—Crohn's disease	0.00201	0.0113	CbGeAlD
Cabergoline—Cardiac disorder—Mesalazine—Crohn's disease	0.00197	0.00466	CcSEcCtD
Cabergoline—HTR2A—smooth muscle tissue—Crohn's disease	0.00194	0.0109	CbGeAlD
Cabergoline—Euphoric mood—Prednisone—Crohn's disease	0.00193	0.00454	CcSEcCtD
Cabergoline—Diarrhoea—Mercaptopurine—Crohn's disease	0.00191	0.00449	CcSEcCtD
Cabergoline—Ill-defined disorder—Azathioprine—Crohn's disease	0.00189	0.00445	CcSEcCtD
Cabergoline—Alopecia—Mesalazine—Crohn's disease	0.00188	0.00443	CcSEcCtD
Cabergoline—Malaise—Azathioprine—Crohn's disease	0.00183	0.00432	CcSEcCtD
Cabergoline—Flatulence—Mesalazine—Crohn's disease	0.00182	0.0043	CcSEcCtD
Cabergoline—Tension—Mesalazine—Crohn's disease	0.00182	0.00429	CcSEcCtD
Cabergoline—Nervousness—Mesalazine—Crohn's disease	0.0018	0.00424	CcSEcCtD
Cabergoline—Back pain—Mesalazine—Crohn's disease	0.00179	0.00423	CcSEcCtD
Cabergoline—Muscle spasms—Mesalazine—Crohn's disease	0.00178	0.0042	CcSEcCtD
Cabergoline—Vomiting—Mercaptopurine—Crohn's disease	0.00177	0.00418	CcSEcCtD
Cabergoline—Rash—Mercaptopurine—Crohn's disease	0.00176	0.00414	CcSEcCtD
Cabergoline—Dermatitis—Mercaptopurine—Crohn's disease	0.00175	0.00414	CcSEcCtD
Cabergoline—Arthralgia—Azathioprine—Crohn's disease	0.00173	0.00408	CcSEcCtD
Cabergoline—Ill-defined disorder—Mesalazine—Crohn's disease	0.00172	0.00405	CcSEcCtD
Cabergoline—Discomfort—Azathioprine—Crohn's disease	0.00171	0.00403	CcSEcCtD
Cabergoline—Malaise—Mesalazine—Crohn's disease	0.00167	0.00394	CcSEcCtD
Cabergoline—Cardiac failure—Prednisone—Crohn's disease	0.00167	0.00393	CcSEcCtD
Cabergoline—Vertigo—Mesalazine—Crohn's disease	0.00166	0.00392	CcSEcCtD
Cabergoline—Syncope—Mesalazine—Crohn's disease	0.00166	0.00392	CcSEcCtD
Cabergoline—Nausea—Mercaptopurine—Crohn's disease	0.00165	0.0039	CcSEcCtD
Cabergoline—Palpitations—Mesalazine—Crohn's disease	0.00164	0.00386	CcSEcCtD
Cabergoline—HTR2B—lymph node—Crohn's disease	0.00164	0.00919	CbGeAlD
Cabergoline—Loss of consciousness—Mesalazine—Crohn's disease	0.00163	0.00384	CcSEcCtD
Cabergoline—Osteoarthritis—Prednisone—Crohn's disease	0.00163	0.00384	CcSEcCtD
Cabergoline—Hypertension—Mesalazine—Crohn's disease	0.0016	0.00377	CcSEcCtD
Cabergoline—Psychotic disorder—Prednisone—Crohn's disease	0.00159	0.00375	CcSEcCtD
Cabergoline—Arthralgia—Mesalazine—Crohn's disease	0.00158	0.00372	CcSEcCtD
Cabergoline—Anxiety—Mesalazine—Crohn's disease	0.00157	0.00371	CcSEcCtD
Cabergoline—Face oedema—Prednisone—Crohn's disease	0.00157	0.00371	CcSEcCtD
Cabergoline—Discomfort—Mesalazine—Crohn's disease	0.00156	0.00367	CcSEcCtD
Cabergoline—Hypotension—Azathioprine—Crohn's disease	0.00155	0.00366	CcSEcCtD
Cabergoline—Dry mouth—Mesalazine—Crohn's disease	0.00154	0.00364	CcSEcCtD
Cabergoline—HTR2A—digestive system—Crohn's disease	0.00153	0.0086	CbGeAlD
Cabergoline—Confusional state—Mesalazine—Crohn's disease	0.00152	0.00359	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00151	0.00357	CcSEcCtD
Cabergoline—Oedema—Mesalazine—Crohn's disease	0.00151	0.00357	CcSEcCtD
Cabergoline—Shock—Mesalazine—Crohn's disease	0.00149	0.00351	CcSEcCtD
Cabergoline—Hyperhidrosis—Mesalazine—Crohn's disease	0.00146	0.00345	CcSEcCtD
Cabergoline—Anorexia—Mesalazine—Crohn's disease	0.00144	0.0034	CcSEcCtD
Cabergoline—CYP3A4—digestive system—Crohn's disease	0.00142	0.00796	CbGeAlD
Cabergoline—Hypotension—Mesalazine—Crohn's disease	0.00141	0.00333	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00138	0.00325	CcSEcCtD
Cabergoline—Sweating increased—Prednisone—Crohn's disease	0.00137	0.00323	CcSEcCtD
Cabergoline—Feeling abnormal—Azathioprine—Crohn's disease	0.00137	0.00323	CcSEcCtD
Cabergoline—Insomnia—Mesalazine—Crohn's disease	0.00137	0.00322	CcSEcCtD
Cabergoline—Paraesthesia—Mesalazine—Crohn's disease	0.00136	0.0032	CcSEcCtD
Cabergoline—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00136	0.0032	CcSEcCtD
Cabergoline—Dyspnoea—Mesalazine—Crohn's disease	0.00135	0.00318	CcSEcCtD
Cabergoline—Somnolence—Mesalazine—Crohn's disease	0.00134	0.00317	CcSEcCtD
Cabergoline—Dyspepsia—Mesalazine—Crohn's disease	0.00133	0.00314	CcSEcCtD
Cabergoline—Decreased appetite—Mesalazine—Crohn's disease	0.00131	0.0031	CcSEcCtD
Cabergoline—Abdominal pain—Azathioprine—Crohn's disease	0.00131	0.00309	CcSEcCtD
Cabergoline—Fatigue—Mesalazine—Crohn's disease	0.0013	0.00307	CcSEcCtD
Cabergoline—Constipation—Mesalazine—Crohn's disease	0.00129	0.00305	CcSEcCtD
Cabergoline—Pain—Mesalazine—Crohn's disease	0.00129	0.00305	CcSEcCtD
Cabergoline—ADRA2C—lymph node—Crohn's disease	0.00129	0.00724	CbGeAlD
Cabergoline—Weight increased—Prednisone—Crohn's disease	0.00128	0.00302	CcSEcCtD
Cabergoline—Weight decreased—Prednisone—Crohn's disease	0.00127	0.003	CcSEcCtD
Cabergoline—Depression—Prednisone—Crohn's disease	0.00125	0.00295	CcSEcCtD
Cabergoline—Feeling abnormal—Mesalazine—Crohn's disease	0.00125	0.00294	CcSEcCtD
Cabergoline—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00124	0.00292	CcSEcCtD
Cabergoline—Hypersensitivity—Azathioprine—Crohn's disease	0.00122	0.00288	CcSEcCtD
Cabergoline—Abdominal pain—Mesalazine—Crohn's disease	0.00119	0.00282	CcSEcCtD
Cabergoline—Diarrhoea—Azathioprine—Crohn's disease	0.00114	0.00268	CcSEcCtD
Cabergoline—Hallucination—Prednisone—Crohn's disease	0.00112	0.00264	CcSEcCtD
Cabergoline—Hypersensitivity—Mesalazine—Crohn's disease	0.00111	0.00263	CcSEcCtD
Cabergoline—Dizziness—Azathioprine—Crohn's disease	0.0011	0.00259	CcSEcCtD
Cabergoline—Asthenia—Mesalazine—Crohn's disease	0.00108	0.00256	CcSEcCtD
Cabergoline—Pruritus—Mesalazine—Crohn's disease	0.00107	0.00252	CcSEcCtD
Cabergoline—Vomiting—Azathioprine—Crohn's disease	0.00105	0.00249	CcSEcCtD
Cabergoline—Rash—Azathioprine—Crohn's disease	0.00105	0.00247	CcSEcCtD
Cabergoline—Dermatitis—Azathioprine—Crohn's disease	0.00105	0.00247	CcSEcCtD
Cabergoline—Headache—Azathioprine—Crohn's disease	0.00104	0.00245	CcSEcCtD
Cabergoline—Diarrhoea—Mesalazine—Crohn's disease	0.00103	0.00244	CcSEcCtD
Cabergoline—ADRA2A—lymph node—Crohn's disease	0.00103	0.00577	CbGeAlD
Cabergoline—Arrhythmia—Prednisone—Crohn's disease	0.00101	0.00237	CcSEcCtD
Cabergoline—Dizziness—Mesalazine—Crohn's disease	0.000999	0.00236	CcSEcCtD
Cabergoline—Alopecia—Prednisone—Crohn's disease	0.000995	0.00235	CcSEcCtD
Cabergoline—Nausea—Azathioprine—Crohn's disease	0.000985	0.00232	CcSEcCtD
Cabergoline—Vomiting—Mesalazine—Crohn's disease	0.000961	0.00227	CcSEcCtD
Cabergoline—Rash—Mesalazine—Crohn's disease	0.000953	0.00225	CcSEcCtD
Cabergoline—Dermatitis—Mesalazine—Crohn's disease	0.000952	0.00225	CcSEcCtD
Cabergoline—Headache—Mesalazine—Crohn's disease	0.000947	0.00223	CcSEcCtD
Cabergoline—Ill-defined disorder—Prednisone—Crohn's disease	0.000909	0.00214	CcSEcCtD
Cabergoline—Nausea—Mesalazine—Crohn's disease	0.000898	0.00212	CcSEcCtD
Cabergoline—Malaise—Prednisone—Crohn's disease	0.000883	0.00208	CcSEcCtD
Cabergoline—Vertigo—Prednisone—Crohn's disease	0.00088	0.00208	CcSEcCtD
Cabergoline—Syncope—Prednisone—Crohn's disease	0.000879	0.00207	CcSEcCtD
Cabergoline—Loss of consciousness—Prednisone—Crohn's disease	0.000861	0.00203	CcSEcCtD
Cabergoline—Hypertension—Prednisone—Crohn's disease	0.000846	0.002	CcSEcCtD
Cabergoline—Arthralgia—Prednisone—Crohn's disease	0.000834	0.00197	CcSEcCtD
Cabergoline—Anxiety—Prednisone—Crohn's disease	0.000831	0.00196	CcSEcCtD
Cabergoline—Discomfort—Prednisone—Crohn's disease	0.000824	0.00194	CcSEcCtD
Cabergoline—Oedema—Prednisone—Crohn's disease	0.0008	0.00189	CcSEcCtD
Cabergoline—Shock—Prednisone—Crohn's disease	0.000787	0.00186	CcSEcCtD
Cabergoline—Hyperhidrosis—Prednisone—Crohn's disease	0.000773	0.00182	CcSEcCtD
Cabergoline—Anorexia—Prednisone—Crohn's disease	0.000762	0.0018	CcSEcCtD
Cabergoline—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000728	0.00172	CcSEcCtD
Cabergoline—Insomnia—Prednisone—Crohn's disease	0.000723	0.00171	CcSEcCtD
Cabergoline—Paraesthesia—Prednisone—Crohn's disease	0.000718	0.00169	CcSEcCtD
Cabergoline—Dyspepsia—Prednisone—Crohn's disease	0.000704	0.00166	CcSEcCtD
Cabergoline—Decreased appetite—Prednisone—Crohn's disease	0.000695	0.00164	CcSEcCtD
Cabergoline—Fatigue—Prednisone—Crohn's disease	0.000689	0.00163	CcSEcCtD
Cabergoline—Constipation—Prednisone—Crohn's disease	0.000684	0.00161	CcSEcCtD
Cabergoline—Feeling abnormal—Prednisone—Crohn's disease	0.000659	0.00155	CcSEcCtD
Cabergoline—Gastrointestinal pain—Prednisone—Crohn's disease	0.000654	0.00154	CcSEcCtD
Cabergoline—Abdominal pain—Prednisone—Crohn's disease	0.000632	0.00149	CcSEcCtD
Cabergoline—Hypersensitivity—Prednisone—Crohn's disease	0.000589	0.00139	CcSEcCtD
Cabergoline—Asthenia—Prednisone—Crohn's disease	0.000574	0.00135	CcSEcCtD
Cabergoline—Pruritus—Prednisone—Crohn's disease	0.000566	0.00133	CcSEcCtD
Cabergoline—Diarrhoea—Prednisone—Crohn's disease	0.000547	0.00129	CcSEcCtD
Cabergoline—Dizziness—Prednisone—Crohn's disease	0.000529	0.00125	CcSEcCtD
Cabergoline—Vomiting—Prednisone—Crohn's disease	0.000508	0.0012	CcSEcCtD
Cabergoline—Rash—Prednisone—Crohn's disease	0.000504	0.00119	CcSEcCtD
Cabergoline—Dermatitis—Prednisone—Crohn's disease	0.000504	0.00119	CcSEcCtD
Cabergoline—Headache—Prednisone—Crohn's disease	0.000501	0.00118	CcSEcCtD
Cabergoline—Nausea—Prednisone—Crohn's disease	0.000475	0.00112	CcSEcCtD
Cabergoline—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	5.6e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	5.6e-05	0.000141	CbGpPWpGaD
Cabergoline—DRD3—GPCR downstream signaling—CXCL8—Crohn's disease	5.6e-05	0.000141	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	5.59e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	5.58e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	5.57e-05	0.00014	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—JAK2—Crohn's disease	5.57e-05	0.00014	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—UBE2D1—Crohn's disease	5.56e-05	0.00014	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	5.54e-05	0.000139	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	5.53e-05	0.000139	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL2RA—Crohn's disease	5.51e-05	0.000138	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—MTMR3—Crohn's disease	5.51e-05	0.000138	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RIPK2—Crohn's disease	5.48e-05	0.000138	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	5.46e-05	0.000137	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—CXCL8—Crohn's disease	5.46e-05	0.000137	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	5.46e-05	0.000137	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	5.45e-05	0.000137	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RIPK2—Crohn's disease	5.39e-05	0.000135	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—SMAD3—Crohn's disease	5.36e-05	0.000135	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL3—Crohn's disease	5.35e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	5.34e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	5.33e-05	0.000134	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	5.32e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—JAK2—Crohn's disease	5.32e-05	0.000134	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SOCS1—Crohn's disease	5.31e-05	0.000133	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—SMAD3—Crohn's disease	5.29e-05	0.000133	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	5.29e-05	0.000133	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	5.28e-05	0.000133	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	5.27e-05	0.000132	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL3—Crohn's disease	5.26e-05	0.000132	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—TYK2—Crohn's disease	5.26e-05	0.000132	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL2RA—Crohn's disease	5.26e-05	0.000132	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	5.2e-05	0.000131	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	5.17e-05	0.00013	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—RASGRP1—Crohn's disease	5.17e-05	0.00013	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	5.16e-05	0.00013	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—CXCL8—Crohn's disease	5.15e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL3—Crohn's disease	5.15e-05	0.000129	CbGpPWpGaD
Cabergoline—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	5.1e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	5.09e-05	0.000128	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—RASGRP1—Crohn's disease	5.09e-05	0.000128	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	5.09e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	5.08e-05	0.000128	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—CXCL8—Crohn's disease	5.08e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	5.08e-05	0.000128	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	5.07e-05	0.000127	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—TYK2—Crohn's disease	5.06e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	5.06e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	5.05e-05	0.000127	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	5.03e-05	0.000126	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—JAK2—Crohn's disease	5.02e-05	0.000126	CbGpPWpGaD
Cabergoline—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	4.99e-05	0.000125	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	4.98e-05	0.000125	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	4.96e-05	0.000125	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL2RA—Crohn's disease	4.96e-05	0.000125	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	4.92e-05	0.000124	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	4.91e-05	0.000123	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL2RA—Crohn's disease	4.89e-05	0.000123	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	4.89e-05	0.000123	CbGpPWpGaD
Cabergoline—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.88e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	4.85e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.85e-05	0.000122	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	4.84e-05	0.000122	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—JAK2—Crohn's disease	4.83e-05	0.000121	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	4.82e-05	0.000121	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL3—Crohn's disease	4.79e-05	0.00012	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	4.77e-05	0.00012	CbGpPWpGaD
Cabergoline—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	4.72e-05	0.000119	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	4.71e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	4.7e-05	0.000118	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—JAK2—Crohn's disease	4.69e-05	0.000118	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SOCS1—Crohn's disease	4.68e-05	0.000118	CbGpPWpGaD
Cabergoline—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	4.64e-05	0.000117	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	4.63e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	4.63e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	4.62e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—JAK2—Crohn's disease	4.62e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SOCS1—Crohn's disease	4.61e-05	0.000116	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	4.61e-05	0.000116	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	4.59e-05	0.000115	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—SMAD3—Crohn's disease	4.58e-05	0.000115	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—CXCL8—Crohn's disease	4.58e-05	0.000115	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	4.53e-05	0.000114	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	4.52e-05	0.000114	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	4.51e-05	0.000113	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—TYK2—Crohn's disease	4.47e-05	0.000112	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	4.46e-05	0.000112	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	4.46e-05	0.000112	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	4.43e-05	0.000111	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	4.42e-05	0.000111	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—CXCL8—Crohn's disease	4.41e-05	0.000111	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—TYK2—Crohn's disease	4.39e-05	0.00011	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	4.39e-05	0.00011	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	4.36e-05	0.00011	CbGpPWpGaD
Cabergoline—DRD5—Signaling by GPCR—IL6—Crohn's disease	4.35e-05	0.000109	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	4.3e-05	0.000108	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—FADS1—Crohn's disease	4.29e-05	0.000108	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	4.29e-05	0.000108	CbGpPWpGaD
Cabergoline—DRD2—GPCR downstream signaling—CXCL8—Crohn's disease	4.28e-05	0.000108	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	4.26e-05	0.000107	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—JAK2—Crohn's disease	4.26e-05	0.000107	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL2RA—Crohn's disease	4.24e-05	0.000107	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	4.22e-05	0.000106	CbGpPWpGaD
Cabergoline—HTR2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.21e-05	0.000106	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	4.2e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	4.19e-05	0.000105	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—JAK2—Crohn's disease	4.19e-05	0.000105	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	4.13e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	4.13e-05	0.000104	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	4.1e-05	0.000103	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	4.06e-05	0.000102	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—TYK2—Crohn's disease	4.05e-05	0.000102	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—SMAD3—Crohn's disease	4.04e-05	0.000102	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—TYK2—Crohn's disease	4.03e-05	0.000101	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GPX4—Crohn's disease	4.02e-05	0.000101	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	4e-05	0.0001	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—SMAD3—Crohn's disease	3.98e-05	9.99e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—TYK2—Crohn's disease	3.94e-05	9.91e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	3.9e-05	9.79e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—CXCL8—Crohn's disease	3.89e-05	9.77e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—TYK2—Crohn's disease	3.88e-05	9.75e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—GCKR—Crohn's disease	3.88e-05	9.74e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—JAK2—Crohn's disease	3.87e-05	9.72e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—JAK2—Crohn's disease	3.84e-05	9.65e-05	CbGpPWpGaD
Cabergoline—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	3.83e-05	9.63e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—CXCL8—Crohn's disease	3.83e-05	9.61e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	3.81e-05	9.58e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—JAK2—Crohn's disease	3.76e-05	9.45e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	3.75e-05	9.41e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL2RA—Crohn's disease	3.74e-05	9.4e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—TYK2—Crohn's disease	3.71e-05	9.31e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—JAK2—Crohn's disease	3.7e-05	9.3e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL2RA—Crohn's disease	3.68e-05	9.25e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—STAT3—Crohn's disease	3.68e-05	9.25e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	3.62e-05	9.09e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	3.61e-05	9.06e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—ALB—Crohn's disease	3.57e-05	8.96e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—JAK2—Crohn's disease	3.53e-05	8.88e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—CXCL8—Crohn's disease	3.53e-05	8.87e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	3.51e-05	8.81e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—TYK2—Crohn's disease	3.49e-05	8.78e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	3.48e-05	8.74e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—TYK2—Crohn's disease	3.45e-05	8.66e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	3.45e-05	8.66e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	3.43e-05	8.63e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—CXCL8—Crohn's disease	3.38e-05	8.49e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling by GPCR—IL6—Crohn's disease	3.36e-05	8.43e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	3.35e-05	8.42e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling by GPCR—IL6—Crohn's disease	3.34e-05	8.38e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—JAK2—Crohn's disease	3.33e-05	8.37e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—JAK2—Crohn's disease	3.29e-05	8.26e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	3.29e-05	8.26e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling by GPCR—IL6—Crohn's disease	3.27e-05	8.2e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—CXCL8—Crohn's disease	3.23e-05	8.1e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling by GPCR—IL6—Crohn's disease	3.21e-05	8.07e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—TYK2—Crohn's disease	3.14e-05	7.89e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Metabolism—PTGS2—Crohn's disease	3.12e-05	7.84e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	3.11e-05	7.82e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—TYK2—Crohn's disease	3.07e-05	7.72e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling by GPCR—IL6—Crohn's disease	3.07e-05	7.7e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—CXCL8—Crohn's disease	3.04e-05	7.64e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—TYK2—Crohn's disease	3e-05	7.55e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—CXCL8—Crohn's disease	3e-05	7.54e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	3e-05	7.54e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—JAK2—Crohn's disease	3e-05	7.53e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—TYK2—Crohn's disease	2.99e-05	7.51e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	2.97e-05	7.46e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—JAK2—Crohn's disease	2.93e-05	7.36e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	2.91e-05	7.3e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—ALB—Crohn's disease	2.9e-05	7.28e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling by GPCR—IL6—Crohn's disease	2.89e-05	7.27e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—JAK2—Crohn's disease	2.87e-05	7.2e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	2.86e-05	7.19e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	2.85e-05	7.17e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling by GPCR—IL6—Crohn's disease	2.85e-05	7.17e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—JAK2—Crohn's disease	2.85e-05	7.16e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—STAT3—Crohn's disease	2.84e-05	7.13e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—STAT3—Crohn's disease	2.82e-05	7.08e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	2.77e-05	6.97e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—STAT3—Crohn's disease	2.76e-05	6.94e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	2.74e-05	6.87e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	2.73e-05	6.86e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—STAT3—Crohn's disease	2.72e-05	6.83e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	2.71e-05	6.81e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	2.68e-05	6.72e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—TYK2—Crohn's disease	2.64e-05	6.63e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	2.62e-05	6.57e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—CXCL8—Crohn's disease	2.6e-05	6.54e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling by GPCR—IL6—Crohn's disease	2.6e-05	6.53e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—TYK2—Crohn's disease	2.6e-05	6.52e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—STAT3—Crohn's disease	2.59e-05	6.52e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	2.58e-05	6.47e-05	CbGpPWpGaD
Cabergoline—DRD5—Signaling Pathways—IL6—Crohn's disease	2.57e-05	6.46e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling by GPCR—IL6—Crohn's disease	2.54e-05	6.39e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	2.54e-05	6.38e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Metabolism—PTGS2—Crohn's disease	2.54e-05	6.37e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	2.53e-05	6.36e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—JAK2—Crohn's disease	2.52e-05	6.32e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	2.49e-05	6.26e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling by GPCR—IL6—Crohn's disease	2.49e-05	6.25e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—JAK2—Crohn's disease	2.48e-05	6.22e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling by GPCR—IL6—Crohn's disease	2.48e-05	6.22e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—STAT3—Crohn's disease	2.45e-05	6.14e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.42e-05	6.09e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	2.41e-05	6.06e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—STAT3—Crohn's disease	2.41e-05	6.06e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	2.41e-05	6.05e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	2.37e-05	5.95e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.36e-05	5.93e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—CXCL8—Crohn's disease	2.3e-05	5.77e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—CXCL8—Crohn's disease	2.26e-05	5.68e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.25e-05	5.66e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.21e-05	5.56e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—STAT3—Crohn's disease	2.2e-05	5.52e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling by GPCR—IL6—Crohn's disease	2.18e-05	5.49e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	2.18e-05	5.47e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—STAT3—Crohn's disease	2.15e-05	5.4e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling by GPCR—IL6—Crohn's disease	2.15e-05	5.4e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.1e-05	5.29e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.1e-05	5.28e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—STAT3—Crohn's disease	2.09e-05	5.26e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.06e-05	5.16e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	2.04e-05	5.11e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	2e-05	5.03e-05	CbGpPWpGaD
Cabergoline—HTR7—Signaling Pathways—IL6—Crohn's disease	1.98e-05	4.98e-05	CbGpPWpGaD
Cabergoline—HTR1D—Signaling Pathways—IL6—Crohn's disease	1.97e-05	4.95e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	1.96e-05	4.91e-05	CbGpPWpGaD
Cabergoline—HTR1B—Signaling Pathways—IL6—Crohn's disease	1.93e-05	4.85e-05	CbGpPWpGaD
Cabergoline—DRD4—Signaling Pathways—IL6—Crohn's disease	1.9e-05	4.77e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—STAT3—Crohn's disease	1.85e-05	4.64e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—STAT3—Crohn's disease	1.82e-05	4.57e-05	CbGpPWpGaD
Cabergoline—HTR2B—Signaling Pathways—IL6—Crohn's disease	1.81e-05	4.55e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	1.78e-05	4.47e-05	CbGpPWpGaD
Cabergoline—DRD1—Signaling Pathways—IL6—Crohn's disease	1.71e-05	4.29e-05	CbGpPWpGaD
Cabergoline—DRD3—Signaling Pathways—IL6—Crohn's disease	1.69e-05	4.24e-05	CbGpPWpGaD
Cabergoline—ADRA1D—Signaling Pathways—IL6—Crohn's disease	1.69e-05	4.24e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	1.65e-05	4.15e-05	CbGpPWpGaD
Cabergoline—ADRB1—Signaling Pathways—IL6—Crohn's disease	1.54e-05	3.86e-05	CbGpPWpGaD
Cabergoline—ADRA2B—Signaling Pathways—IL6—Crohn's disease	1.52e-05	3.82e-05	CbGpPWpGaD
Cabergoline—ADRB2—Signaling Pathways—IL6—Crohn's disease	1.5e-05	3.77e-05	CbGpPWpGaD
Cabergoline—HTR1A—Signaling Pathways—IL6—Crohn's disease	1.47e-05	3.69e-05	CbGpPWpGaD
Cabergoline—HTR2C—Signaling Pathways—IL6—Crohn's disease	1.46e-05	3.67e-05	CbGpPWpGaD
Cabergoline—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.42e-05	3.57e-05	CbGpPWpGaD
Cabergoline—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.4e-05	3.52e-05	CbGpPWpGaD
Cabergoline—DRD2—Signaling Pathways—IL6—Crohn's disease	1.29e-05	3.24e-05	CbGpPWpGaD
Cabergoline—HTR2A—Signaling Pathways—IL6—Crohn's disease	1.27e-05	3.19e-05	CbGpPWpGaD
Cabergoline—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.24e-05	3.12e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—ALB—Crohn's disease	1.23e-05	3.1e-05	CbGpPWpGaD
Cabergoline—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.16e-05	2.9e-05	CbGpPWpGaD
Cabergoline—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.08e-05	2.71e-05	CbGpPWpGaD
